In the UK, concerns over a potential second wave of vCJD in individuals from different PRNP codon 129 genotypes resurfaced in 2017, following the first report of pathologically confirmed vCJD in a PRNP codon 129 MV patient (Figure 1) [84]. This evidence concerns the gene PRNP and variant Creutzfeldt-Jakob disease.